Annual Open Enrollment is here once again, and as we know, healthcare costs continue to rise across the US. In preparation for the 2025 plan year, Sasser Family Companies has thoroughly explored alternative programs, negotiated with vendors, and sought cost-effective solutions to keep expenses as low as possible for both the company and its employees.

For the 2025 plan year, we are implementing changes. Similar to the 2024 plan year, our plan faced another significant cost increase from our medical carrier, BlueCross BlueShield of IL. To continue making the plans affordable for both Sasser and you as a member, the design of the plans and the rates will be changing.

We utilized national benchmark data to ensure our plans remain competitive within the industry, considering employer size and geographic locations. We continue to strive for competitive pricing and excellent plan service.

What Is Changing For the New Plan Year

• Medical Plan Design & Premium Rates
• Medication Formulary Listing
• NEW GLP-1 requirement
• NEW Flex Access Specialty Medication Program
• New FSA & HSA Maximums

Prime Therapeutics Formulary Listing

Through our due diligence, we reviewed alternative formulary options with BCBSIL’s pharmacy benefit manager. Transitioning from the Balanced Formulary to the Performance Formulary will cause minimal disruption to current medications and will result in savings for both the plan and all members. Medications that will transition to excluded are currently covered under the generic category and include those that can be purchased over the counter, such as allergy medications. Please watch for notifications from BCBSIL | Prime Therapeutics if you are currently taking a medication that may be affected by this transition.

GLP-1 Diabetic Medications

These medications have become popular for weight loss however all are not FDA approved for weight loss. BCBSIL has put protections in place that will begin in 2025 that will require anyone whose provider has submitted a prescription for these medications to go through prior authorization process to ensure that the medication is being use based on the FDA approved method. (example: Ozempic)

Flex Access Specialty Program

Members may receive outreach from Prime Therapeutics regarding the Flex Access Specialty Program. Participation in this program is free and can help you lower the cost of your specialty medications, potentially reducing the cost to zero. The program focuses on high-cost medications where the manufacturer offers copay assistance. Prime will assist you in getting registered and approved. If you receive information or phone calls after January 1st, please note that Sasser has engaged in this program as part of our efforts to help you save on costs, and it is legitimate.

BCBSIL Medical ID Cards

With the changes to our plans, BCBSIL will be sending out new ID cards to all those who enroll or remain enrolled for 2025. These ID cards will most likely be delayed due to the time of year and you may not receive them until sometime in January.  However, your current insurance card will still work in the meantime. Please be rest assured that you have coverage if you are enrolled and can seek services. You can always check your BCBSIL Mobile App for the updated ID card as it will post to the portal faster than the mail.